Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1977 Nov;36(5):601–607. doi: 10.1038/bjc.1977.237

Secretion of prostaglandins as bone-resorbing agents by renal cortical carcinoma in culture.

D Atkins, K J Ibbotson, K Hillier, N H Hunt, J C Hammonds, T J Martin
PMCID: PMC2025405  PMID: 201261

Abstract

Fragments of human renal carcinoma tissue have been co-cultured with mouse calvaria. In 9/13 cases significant bone resorption occurred whilst in no case did control kidney cause significant resorption. When bone resorption did occur, it could be reduced by inclusion of indomethacin in the culture medium. In some cases when theophylline was included in culture medium to prevent cyclic AMP breakdown, there was enhancement of tumour-induced bone resorption. Control studies without tumour showed that none of the experimental treatments had a direct effect on bone. Radioimmunoassay of prostaglandin E (PGE) levels in pooled culture media showed that tumour fragments produced appreciable amounts of PGE, and that this production was lowered by indomethacin and increased by theophylline. It is concluded that the bone resorption induced by these tumours is due to a prostaglandin, and that prostaglandin production may be controlled by changes in cyclic AMP metabolism.

Full text

PDF
601

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkins D., Peacock M. A comparison of the effects of the calcitonins, steroid hormones and thyroid hormones on the response of bone to parathyroid hormone in tissue culture. J Endocrinol. 1975 Mar;64(3):573–583. [PubMed] [Google Scholar]
  2. Atkins D., Zanelli J. M., Peacock M., Nordin B. E. The effect of oestrogens on the response of bone to parathyroid hormone in vitro. J Endocrinol. 1972 Jul;54(1):107–117. doi: 10.1677/joe.0.0540107. [DOI] [PubMed] [Google Scholar]
  3. Bennett A., McDonald A. M., Simpson J. S., Stamford I. F. Breast cancer, prostaglandins, and bone metastases. Lancet. 1975 May 31;1(7918):1218–1220. doi: 10.1016/s0140-6736(75)92197-2. [DOI] [PubMed] [Google Scholar]
  4. Benson R. C., Jr, Riggs B. L., Pickard B. M., Arnaud C. D. Radioimmunoassay of parathyroid hormone in hypercalcemic patients with malignant disease. Am J Med. 1974 Jun;56(6):821–826. doi: 10.1016/0002-9343(74)90810-9. [DOI] [PubMed] [Google Scholar]
  5. Brereton H. D., Halushka P. V., Alexander R. W., Mason D. M., Keiser H. R., DeVita V. T., Jr Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma. N Engl J Med. 1974 Jun 11;291(2):83–85. doi: 10.1056/NEJM197407112910207. [DOI] [PubMed] [Google Scholar]
  6. Brown B. L., Albano J. D., Ekins R. P., Sgherzi A. M. A simple and sensitive saturation assay method for the measurement of adenosine 3':5'-cyclic monophosphate. Biochem J. 1971 Feb;121(3):561–562. doi: 10.1042/bj1210561. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Buckle R. M., McMillan M., Mallinson C. Ectopic secretion of parathyroid hormone by a renal adenocarcinoma in a patient with hypercalcaemia. Br Med J. 1970 Dec 19;4(5737):724–726. doi: 10.1136/bmj.4.5737.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Chase L. R., Aurbach G. D. The effect of parathyroid hormone on the concentration of adenosine 3',5'-monophosphate in skeletal tissue in vitro. J Biol Chem. 1970 Apr 10;245(7):1520–1526. [PubMed] [Google Scholar]
  9. Dowsett M., Easty G. C., Powles T. J., Easty D. M., Neville A. M. Human breast tumour-induced osteolysis and prostaglandins. Prostaglandins. 1976 Mar;11(3):447–460. doi: 10.1016/0090-6980(76)90078-2. [DOI] [PubMed] [Google Scholar]
  10. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  11. Galasko C. S., Bennett A. Relationship of bone destruction in skeletal metastases to osteoclast activation and prostaglandins. Nature. 1976 Oct 7;263(5577):508–510. doi: 10.1038/263508a0. [DOI] [PubMed] [Google Scholar]
  12. Greenberg P. B., Martin T. J., Sutcliffe H. S. Synthesis and release of parathyroid hormone by a renal carcinoma in cell culture. Clin Sci Mol Med. 1973 Aug;45(2):183–191. doi: 10.1042/cs0450183. [DOI] [PubMed] [Google Scholar]
  13. Heath D. A. Hypercalcaemia and malignancy. Ann Clin Biochem. 1976 Nov;13(6):555–560. doi: 10.1177/000456327601300159. [DOI] [PubMed] [Google Scholar]
  14. Hillier K., Dilley S. R. Separation and radioimmunoassay of f alpha prostaglandins using silica gel micro columns. Prostaglandins. 1974 Jan 25;5(2):137–150. doi: 10.1016/s0090-6980(74)80105-x. [DOI] [PubMed] [Google Scholar]
  15. Jaffe B. M. Prostaglandins and cancer: an update. Prostaglandins. 1974 Jun 25;6(6):453–461. doi: 10.1016/s0090-6980(74)80055-9. [DOI] [PubMed] [Google Scholar]
  16. Klein D. C., Raisz L. G. Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970 Jun;86(6):1436–1440. doi: 10.1210/endo-86-6-1436. [DOI] [PubMed] [Google Scholar]
  17. Klein D. C., Raisz L. G. Role of adenosine-3',5'-monophosphate in the hormonal regulation of bone resorption: studies with cultured fetal bone. Endocrinology. 1971 Sep;89(3):818–826. doi: 10.1210/endo-89-3-818. [DOI] [PubMed] [Google Scholar]
  18. Lawson D. E., Fraser D. R., Kodicek E., Morris H. R., Williams D. H. Identification of 1,25-dihydroxycholecalciferol, a new kidney hormone controlling calcium metabolism. Nature. 1971 Mar 26;230(5291):228–230. doi: 10.1038/230228a0. [DOI] [PubMed] [Google Scholar]
  19. Lee J. B., Attallah A. A. Renal prostaglandins. Nephron. 1975;15(3-5):350–368. doi: 10.1159/000180520. [DOI] [PubMed] [Google Scholar]
  20. Moseley J. M., Martin T. J., Robinson C. J., Reit B. W., Tregear G. W. Hormone metabolism and response of adenylate cyclase to parathyroid hormone in kidney. Clin Exp Pharmacol Physiol. 1975 Nov-Dec;2(6):549–557. doi: 10.1111/j.1440-1681.1975.tb01860.x. [DOI] [PubMed] [Google Scholar]
  21. Perry-Keene D. A., Connelly J. F., Young R. A., Wettenhall H. N., Martin F. I. Hypothalamic hypopituitarism following external radiotherapy for tumours distant from the adenohypophysis. Clin Endocrinol (Oxf) 1976 Jul;5(4):373–380. doi: 10.1111/j.1365-2265.1976.tb01965.x. [DOI] [PubMed] [Google Scholar]
  22. Powell D., Singer F. R., Murray T. M., Minkin C., Potts J. T., Jr Nonparathyroid humoral hypercalcemia in patients with neoplastic diseases. N Engl J Med. 1973 Jul 26;289(4):176–181. doi: 10.1056/NEJM197307262890403. [DOI] [PubMed] [Google Scholar]
  23. Powles T. J., Clark S. A., Easty D. M., Easty G. C., Neville A. M. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer. Br J Cancer. 1973 Oct;28(4):316–321. doi: 10.1038/bjc.1973.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Raisz L. G., Dietrich J. W., Simmons H. A., Seyberth H. W., Hubbard W., Oates J. A. Effect of prostaglaidin endoperoxides and metabolites on bone resorption in vitro. Nature. 1977 Jun 9;267(5611):532–534. doi: 10.1038/267532a0. [DOI] [PubMed] [Google Scholar]
  25. Rees L. H. The biosynthesis of hormones by non-endocrine tumours--a review. J Endocrinol. 1975 Oct;67(1):143–175. doi: 10.1677/joe.0.0670143. [DOI] [PubMed] [Google Scholar]
  26. Seyberth H. W., Segre G. V., Morgan J. L., Sweetman B. J., Potts J. T., Jr, Oates J. A. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med. 1975 Dec 18;293(25):1278–1283. doi: 10.1056/NEJM197512182932502. [DOI] [PubMed] [Google Scholar]
  27. Tashjian A. H., Jr, Tice J. E., Sides K. Biological activities of prostaglandin analogues and metabolites on bone in organ culture. Nature. 1977 Apr 14;266(5603):645–647. doi: 10.1038/266645a0. [DOI] [PubMed] [Google Scholar]
  28. Tashjian A. H., Jr, Voelkel E. F., Levine L. Effects of hydrocortisone on the hypercalcemia and plasma levels of 13,14-dihydro-15-keto-prostaglandin E2 in mice bearing the HSDM1 fibrosarcoma. Biochem Biophys Res Commun. 1977 Jan 10;74(1):199–207. doi: 10.1016/0006-291x(77)91394-8. [DOI] [PubMed] [Google Scholar]
  29. Tashjian A. H., Jr, Voelkel E. F., Levine L., Goldhaber P. Evidence that the bone resorption-stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E 2 . A new model for the hypercalcemia of cancer. J Exp Med. 1972 Dec 1;136(6):1329–1343. doi: 10.1084/jem.136.6.1329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Webster L. A., Atkins D., Peacock M. A bioassay for parathyroid hormone using whole mouse calvaria in tissue culture. J Endocrinol. 1974 Sep;62(3):631–637. doi: 10.1677/joe.0.0620631. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES